FTY720 Abrogates the Therapeutic Potential of Adoptively Transferred Treg Via 
Inhibition of IL-2 Induced in Vivo Expansion.

Wolf, A. M.; Hochegger, K.; Zeiser, R.; Duerr, C.; Sixt, M.; Rosenkranz, A.; Gastl, G.; Wolf, D.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

FTY720 Abrogates the Therapeutic Potential of Adoptively Transferred Treg Via Inhibition of IL-2 Induced in Vivo Expansion.

MPS-Authors

/persons/resource/persons78718

Sixt, M.
Fässler, Reinhard / Molecular Medicine, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Wolf, A. M., Hochegger, K., Zeiser, R., Duerr, C., Sixt, M., Rosenkranz, A., et al. (2008). FTY720 Abrogates the Therapeutic Potential of Adoptively Transferred Treg Via Inhibition of IL-2 Induced in Vivo Expansion. Blood, 112(11), 896-896.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-5B5F-D

Abstract

There is no abstract available